Day Care Cancer Treatment and Chemotherapy Administration.
Screening and Diagnostic Support
Chronic Diseases Care: Hypertension, Diabetes, Dyslipidemia etc.
Management of Bleeding and Blood related disorders
Survivorship care and Follow Ups.
Welcome to Beacon Health Services.
Beacon Health Services : Medical and Cancer Treatment Center has a United States of America trained internist, Hematologist and Medical Oncologist. Patients are given the highest quality of personalized clinical care with most cutting edge and latest highly effective therapies.
* Moses A satisfied Patient
Featured: Why do cancers come back?
Cancer recurrence is defined as the return of cancer after treatment and after a period of time during which the cancer cannot be detected. The same cancer may come back where it first started or somewhere else in the body.
Cancer may come back some time after its initial treatment. This idea can be frightening. There are a number of different reasons for why cancer might come back.One reason is that the original treatment did not get rid of all the cancer cells and those that were left grew into a new tumour.
The question is bound to linger in any cancer survivor’s mind: what if it comes back? Cancer can recur even if it seems that treatment was successful. Cancer cells can sometimes linger undetected and slowly regrow until you become symptomatic.
You can now purchase Hydroxyurea from Beacon Health Services.It used by sickle cell patients to prevent painful episodes,decrease rates of hospitalizations and blood transfusions as well as complications of sickle cell disease. Hydroxyurea was first developed as a cancer drug, but with sickle cell anemia it reduces the number of these abnormally shaped red blood cells, the researchers said.
Early results showed that hydroxyurea “works as well as blood transfusions which lowers the risk of the child having a stroke,” principal investigator Dr. Russell Ware, director of hematology at Cincinnati Children’s Hospital Medical Center, said in a center news release.
“This critical research finding opens the door to more treatment options for clinicians trying to prevent strokes in children living with the sickle cell disease,” NHLBI Director Dr. Gary Gibbons said in the news release.